Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease

Gastroenterology

Volumn 108, Issue 1, 1995, Pages 21-33

  Schreiber, Stefan ^a   Heinig, Thomas ^a   Panzer, Ulf ^a   Reinking, Rüdiger ^a   Bouchard, Anja ^a   Stahl, Philipp D ^b   Raedler, Andreas ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR; IODINE 125; MANNOSE; MANNOSE RECEPTOR; MESALAZINE; POKEWEED MITOGEN; RECOMBINANT INTERLEUKIN 4; SALAZOSULFAPYRIDINE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL CALF SERUM; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MONOCYTE; MONONUCLEAR CELL; PHAGOCYTE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0028877556     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90004-7     Document Type: Article

References (47)

1. Activation of peripheral blood and intestinal lymphocytes in Crohn's disease
2. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease
3. Role of interleukin 1 in inflammatory bowel disease—enhanced production during active disease
4. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
5. Increased Activation of Intestinal Lamina Propria Mononuclear Cells in Inflammatory Bowel Disease
6. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
7. Increased concentrations of interleukin 1β, interleukin 2, and soluble interleukin-2 receptors in endoscopic mucosal biopsy specimens with active inflammatory bowel disease
8. Enhanced mucosal cytokine production in inflammatory bowel disease
9. Increased interleukin 2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis
10. Increased release of soluble interleukin-2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease
11. Tumor necrosis factorα, interleukin-1β and interleukin 6 expression in inflammatory bowel disease
12. Monokine profiles in inflammatory bowel disease: detection of messenger RNA by polymerase chain reaction amplification
13. The role of interleukin 1 in disease
14. Interleukin-1 in the pathogenesis of and protection from inflammatory bowel disease
15. Interleukin 1 (IL-1) gene expression, synthesis and effect of specific IL-1 receptor blockade in rabbit immune complex colitis
16. Interleukin-1 and interleukin-1 antagonism
17. Monocytes of patients with Crohn's Disease are Primed for Accentuated Release of Toxic Oxygen Metabolites: Possible Role for Endotoxin
18. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease
19. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes
20. Differential regulation of IL-1 production in human monocytes by IFN-γ and IL-4
21. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumorcidal activity and expression of la antigens
22. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation
23. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4
24. Interleukin-4 is a neutrophil activator
25. Immunosuppression induced by nitric oxide and its inhibition by interleukin 4
26. Isolation of mononuclear cells and granulocytes from human blood
27. Aggregated bovine IgG inhibits mannose receptor expression of murine bone marrow derived macrophages via activation
28. Uptake of glycoproteins and glycoconjugates by macrophages
29. Protein determination for large numbers of samples
30. Prostaglandin E specifically upregulates the expression of the mannose-receptor on mouse bone marrow-derived macrophages
31. Macrophage receptors for lysosomal enzymes
32. Enhancement of macrophage candidacidal activity by interferon-g increased phagocytosis and killing mediated by a decreased number of mannose receptors
33. The attraction of proteins for small molecules and ions
34. Monomeric IgG2a and PGE are involved in the regulation of murine bone marrow macrophage maturation and mannose receptor expression
35. Characterization of the mannose/fucose receptor on human mononuclear phagocytes
36. 2
37. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist
38. Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake
39. IL-10 inhibits cytokine production by activated macrophages
40. Interleukin 10
41. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor
42. Opposite modulatory activity of IL-10 and IL-4 on lamina propria mononuclear cells (LpMC) is stimulus-dependent
43. Immune activation gene products are resistent to IL-4 inhibitory activity in Crohn's disease (CD)
44. Regulation of mouse bone marrow mannose receptor expression and activation by prostaglandin E and IFN-gamma
45. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes
46. Increase of immature macrophages in the intestinal mucosa of IBD patients